Clinical Trials Directory

Trials / Completed

CompletedNCT04891393

The Effects of Caffeine on Human Spinal Motoneurons

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Temple University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.

Detailed description

Recently, it has been shown that human spinal motoneurons do not simply act as a binary control system. Instead, they are regulated by intrinsic properties that can elicit lingering effects on the descending motoneuron. Caffeine, one of the world's most popular over-the-counter supplements, can potentially augment these characteristics of motoneurons. Using decomposition software and non-invasive, high-density surface electromyography, it is possible to extract the characteristics of these motoneurons. This project will utilize a double-blind, inactive-placebo controlled, crossover design study to examine and quantify the effects of caffeine on motoneuron excitability.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCoffeeStarbucks brand "Via" instant coffee. (Caffeine Content: 3 mg / kg)
DIETARY_SUPPLEMENTDecaffeinated coffeeStarbucks brand "Via" instant decaffeinated coffee. (Caffeine Content: 15 - 25 mg)

Timeline

Start date
2021-06-01
Primary completion
2022-03-28
Completion
2022-03-28
First posted
2021-05-18
Last updated
2022-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04891393. Inclusion in this directory is not an endorsement.